CG Oncology, Inc. (CGON) News
Follow CG Oncology, Inc. (CGON) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
CGON: Durable efficacy, operational simplicity, and pivotal trial catalysts drive strong outlook
Key highlights include robust BLA progress for cretostimogene grenadenorepvec, strong differentiation through durable efficacy and operational simplicity, and a well-capitalized position supporting multiple clinical and
NEWS | Sep 14, 2026, 09:59 PM UTC
L
CGON: Durable efficacy, workflow fit, and imminent PIVOT-006 data drive optimism for cretostimogene
Key topics included robust manufacturing and inspection readiness for cretostimogene, strategic launch planning, and differentiation through durable efficacy and workflow advantages. Near-term catalysts include PIVOT-006
NEWS | Sep 14, 2026, 09:42 PM UTC
L
CG Oncology CEO to present at Cantor and Morgan Stanley healthcare conferences
CG Oncology said Arthur Kuan, Chairman, President and Chief Executive Officer, will participate in fireside chats at the Cantor Fitzgerald and Morgan Stanley Global Healthcare Conferences in New York City in September.
EQUITY | Sep 02, 2026, 12:07 PM UTC
L
CGON - CG Oncology to Present at Upcoming Investor Conferences in September
CGON - CG Oncology to Present at Upcoming Investor Conferences in September
EQUITY | Sep 02, 2026, 12:00 PM UTC
L
CGON - CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
CGON - CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
EARNINGS | Aug 06, 2026, 12:15 PM UTC